Therapeutic Area | MeSH |
---|---|
eye diseases | D005128 |
Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Beovu | brolucizumab-dbll | Novartis Pharmaceuticals Corporation | N-761125 RX | 2019-10-07 | 2 products |
Brand Name | Status | Last Update |
---|---|---|
beovu | Biologic Licensing Application | 2024-01-31 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
wet macular degeneration | EFO_0004683 | D057135 | — |
Code | Description |
---|---|
J0179 | Injection, brolucizumab-dbll, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Macular degeneration | D008268 | EFO_0001365 | H35.30 | 1 | 4 | 13 | 5 | 13 | 35 |
Wet macular degeneration | D057135 | EFO_0004683 | — | — | — | 2 | 2 | — | 4 |
Retinal diseases | D012164 | HP_0000479 | H35.9 | — | — | 2 | 1 | — | 3 |
Retinal degeneration | D012162 | HP_0001105 | — | — | — | 2 | 1 | — | 3 |
Eye diseases | D005128 | EFO_0003966 | H44 | — | — | 2 | 1 | — | 3 |
Retinal dystrophies | D058499 | HP_0000556 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Macular edema | D008269 | — | — | — | — | 5 | — | 1 | 6 |
Retinal vein occlusion | D012170 | EFO_1001157 | H34.81 | — | — | 2 | — | — | 2 |
Choroidal neovascularization | D020256 | — | — | — | — | 2 | — | — | 2 |
Edema | D004487 | HP_0000969 | R60.9 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myopia | D009216 | EFO_0003927 | H52.1 | — | — | — | — | 1 | 1 |
Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 1 | 1 |
Drug common name | Brolucizumab |
INN | brolucizumab |
Description | Brolucizumab sold under trade name Beovu among others, is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD).
|
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL3707357 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB14864 |
UNII ID | XSZ53G39H5 (ChemIDplus, GSRS) |